LMAT - Is This Overlooked Stock a Buy After Its Dividend Hike?
Dividend growth investors are arguably best-served by building a diversified portfolio of quality stocks in industries poised for promising future growth.
Investors would have to look long and hard to find a stock that better fits this description than the small-cap medical devices stock LeMaitre Vascular (NASDAQ: LMAT) . The stock just announced a 13.6% boost in its quarterly dividend per share to $0.125.
But is this under-the-radar small-cap stock currently a buy? Let's take a closer look at LeMaitre's fundamentals and valuation to decide.
For further details see:
Is This Overlooked Stock a Buy After Its Dividend Hike?